Regulated Market in Tripura: For Sustainable Local Governance

The farmers are getting poorer despite the increase in the agricultural GDP. The profitability of agriculture has declined while the risk involved has increased.The changes in the policy en v iron ment a n d the market situation have not benefited the small and marginal farmers uniformly. Th e st u dy a tt emp ts t o project the regulated market of Tripura with different amenities available in the market vicinity. Alto gethe r 21 markets have been deliberately studied with twenty numbers of respondents from each market, and a total 420 numbers of responses are recorded; and a z-test has been applied to ascertain the relative importance of the specific variables. The market information, storing, weighing, sorting facilities are significantly aff ec te d on the marketing of agricultural produce in regulated markets of Tripura. In contrast, grading and transportation facilities have been found less affected by the regulated market system in Tri pura . Th e f i rst controlled market was created (1964). Following that, three markets were controlled in 1981, and sevente en markets were regulated in 1986. In Tripura, the government has take n se v e ral me a sure s t o e sta bli sh a controlled market. Despite these measures, there has been no discernible improvement in the state of Tripura's regulated markets

Biosimilar approval and checkpoints

Biologic drugs and subsequently developed biosimilars treat chronic inflammatory autoimmune conditions such as rheumatoid or psoriatic arthritis, ankylosingspondylitis, crohn's disease, ulcerative colitis, and psoriasis. Biologics can target the cancer in a specific way and may work synergistically with chemotherapy to improve outcome. It is expected that in the next five years, 50% of biological products will originate from biotechnology. Biological products, including those manufactured by biotechnology, tend to be heat sensitive and susceptible to microbial contamination. There are no expected clinically meaningful differences in efficacy and safety between a biosimilar and the biologic drugs which are authorized for sale. The global market for Biosimilars is dominated by oncology (nearly 39% share) whereas the total biosimilar market size is expected to reach nearly 70 billion by 2025. Biosimilars are generally marketed at prices 25 to 40 percent below original branded productsie Biologics. The number of biosimilars approved by US FDA are nearly 30. There are about 25 top global manufacturers of biosimilars. Many Domestic companies in India are making strong presence even in regulated markets. (BPCIA) guidelines in the United States (US), mention that a biosimilar can be designated as “interchangeable”, whereby it may be substituted for the reference product (original biological drug).

Corporate Financial Risk Management Interventions in the Organic Agri-Food Chains

This study arises from the need to propose an alternative solution to existing hedging methods to all companies interested in hedging the price risk of raw materials. The research focuses mainly on the actors of the agri-food supply chains, in particular the organic sector, given the growing trend of the cultivation methodology and the need to protect entrepreneurs involved in short-chain spinneret who have less possibility of relieve higher costs incurred to ensure the sustainability of the product. However, our analysis envisages a customizable hedging method for any company that intends to protect itself from the price fluctuations of the commodity that represents the inherent nature of its business. The technique consists in the construction of specific contracts (in particular, derivative financial instruments) by investment banks or commercial banks oriented to the corporate segment that offer this service. Personalization is achieved by calibrating the constituent elements of the derivative on the basis of hedging needs. The parameterization is carried out by replicating the contractual specifications of the main futures on commodities listed on regulated markets. This will allow the creation of a combination of option contracts listed on the over-the-counter market in an overall strategy aimed at medium-long term hedging.

A Study on Performance of Regulated Markets in Tamil Nadu

The aim of the paper is to study the performance of regulated markets in TamilNadu . Regulated markets are essential for regulating and monitoring the financial and economic system thereby reducing market charges and providing facilities to producers and sellers in the market. At present in Tamil Nadu 284 regulated markets are functioning under 23 market committees to ensure fair prices to farmers produce. The primary data were collected by structured questionnaire to study the constraints faced by the farmers in regulated market and also the brain storming session were conducted between market committee, farmers, traders, FPO’s(Farmer Producer Organisation), etc.. to improve the efficiency of regulated market. The secondary data were collected from District market committees. The tools used in this study are Percentage analysis and Garett ranking method. The results shows that nearly 80 to 90 percent of Market fee collected outside, for the sale and purchase of notified agricultural produce would be affected due to the farm bill 2020 and this problems can be fairly rectified by some alternative measures or models in which market shops construction, Primary processing centres, etc.. will improve the performance of the regulated market. The major constraints faced by the farmers was high transportation cost.

A Study on Production and Marketing Constraints of French Bean (Phaseolus vulgaris L.) Growers in Bishnupur District of Manipur

The study was conducted to analyze the production and marketing constraints of French beans in the Bishnupur district of Manipur. The primary data was collected through a personal interview technique from 100 respondent farmers. Garrett's ranking technique was used for the analysis. Higher cost of labor, pesticide and fertilizer, inadequate irrigation facilities, high seed cost, non-availability of labor, credit, and seed on time, and lack of technical guidance and credit facilities were the main constraint’s found during the production. In case of marketing constraints, price fluctuation high perishability of the produce, high transportation cost and lack of transportation and storage facilities, presence of an exploitative middleman, bandhs and strikes, untimely payment of sale, lack of price and market information, and absence of regulated markets were the major constraints. These constraints are giving huge hindrances to the farmers during the production and marketing and hence proper remedies should be imposed so that the production and marketing of this particular crop can be improved efficiently.

The microfoundations of design sprint: how Johnson & Johnson cultivates innovation in a highly regulated market

Purpose Mastering innovation in highly regulated markets might require companies to overcome significant barriers. Rules, laws and limitations on social, economic and institutional dimensions can hinder the ability of a company to transfer knowledge within and across organizational boundaries. However, as recent research in innovation management increasingly advocates user involvement and early understanding of user needs as best practices, the inability to freely interact with customers due to highly regulated market restrictions can hinder the company’s capability to innovate. Hence, this paper aims to shed light on how an emerging managerial approach, such as Design Sprint, can support companies operating in highly regulated markets to overcome user involvement limitations and boost human-centered innovation. Design/methodology/approach This paper sheds light on how to boost innovation in a highly regulated market by leveraging an in-depth case study. The study investigates the use of the Design Sprint approach adopted by the pharmaceutical multinational Johnson & Johnson to revise the way its R&D department orchestrates the new product development process, overcoming the user involvement challenges of highly regulated markets. Findings In analyzing six different projects undertaken in the past two years, the findings illustrate three microfoundational dimensions of the Design Sprint approach in highly regulated markets, the so-called 3T model: team, time and tools. Indeed, deploying the Design Sprint in a highly regulated market has proven that being able to experiment in the early stages, building rough prototypes in real-time and openly collaborating with partners is crucial to boost innovation and anticipate constraints. Originality/value The paper sheds light on the Design Sprint approach by initially grounding an emerging managerial approach on organizational and management theory, leveraging the lens of microfoundations. In doing so, this study suggests how Design Sprint is based on the pillars of experimentation, knowledge transfer and co-creation usually neglected in highly regulated markets where user involvement is challenging. Finally, this study discloses the importance of using a design-based methodology in fostering innovation in highly regulated markets.

12. Market abuse

This chapter deals with abuses committed in the trading of shares, with particular reference to insider dealing and market manipulation, and the laws intended to control them. The chapter considers forms of control to prevent market abuse under three key pieces of legislation: Regulation (EU) No 596/2014, the Criminal Justice Act 1993 and the Financial Services Act 2012. It looks at regulations governing disclosure to regulated markets and the fiduciary duty of directors, and offences involving insider dealing and creating a false market. The chapter analyses a particularly significant case: Percival v Wright [1902] 2 Ch 421.

Policy response to COVID-19 pandemic and related future challenges

The paper reviews new standard policy response to global COVID-19 pandemic led by the IMF. It identifies new innovative approaches in the design of expansionary fiscal support measures and accommodating monetary policy. Particular attention is paid to the treatment of labor markets, job-retention measures, and worker-reallocation efforts deployed at appropriate stages of continued pandemic, initial post-COVID-19 economic recovery and longer-run investment for sustainable future growth. The paper detects inherent policy limitations in the treatment of local, national and global public goods, excessive globalization, and unregulated financial markets and capital mobility, as well as weak integration between prevailing economic policy paradigm and other social sciences. It seeks a solution in expanding economic policy framework beyond neoliberalism, by harnessing democracy and human wellbeing consistent with sustainable development goals through balanced conduct of economic policy, efficient and adequately regulated markets (as needed), and responsible and transparent state actions.